BV Science will be present at IPPE 2018
BV Science, the joint business unit of Vetanco S.A. and Dr. Bata Ltd., will participate in the International Production & Processing Expo 2018 (IPPE), which will be held from January 30 to February 1 in Atlanta, USA.
BV Science will show its product line, including Detoxa Plus Dysantic, Di Heptarine S, Herbanoplex CP, Uniwall Mos 25, and Gamaxine, at booth no. 3211, Hall C. The team will answer technical and sales inquiries in a large space, with a VIP meeting room, semi-exclusive sitting rooms, and customer service points, providing all the conveniences required for work meetings.
”2017 was a year of considerable growth for BV Science. This year, we took a strategic leap by opening a new subsidiary in St. Louis, USA, which will allow launching our most innovative product lines in this important market,” said Martín Cardaci, DVM Vetanco’s Foreign Trade Business Manager.
IPPE is the world’s largest annual event dedicated to the poultry, meat, and feed industries. Leading companies annually participate in IPPE for networking and to learn about the latest technological advances and the challenges faced by the industry.
This year, more than 1,200 exhibitors and 30,000 visitors are expected to participate, among buyers and sellers of state-of-the-art products and services.
In 2016, Vetanco S.A., an international animal health company with a strong commercial presence in the Americas, together with Dr. Bata Co., an European research and development company, announced the merger of their research, marketing, and technical support departments, establishing BV Science. Today, they have joint actions in the Americas, Europe and Asia.
About Vetanco
Vetanco is an international animal health company that develops, manufactures, and markets innovative products for animal health and production since 1987. Present in more than 40 countries, Vetanco offers internationally proven, quality-controlled, and safe products for the improvement of food safety and productivity. Vetanco is an international benchmark in additives and specialties for the animal food industry, with an extensive and diverse product portfolio. The company follows GMP quality standards, which allows it to comply with the requirements of the most demanding markets. In Argentina, it is the second employer in the animal health industry, and the largest exporter of veterinary products. Its teams of professionals coordinate research projects using cutting-edge technology. Its new biotechnology laboratory, its strategic alliance for innovation with Dr. Bata company (Hungary), and the corporate participation in the Bioinnovo-INTA public-private company, created within the framework of the new Biotechnology Act of Argentina, are highlighted.
www.vetanco.com
About Dr. Bata
Dr. Bata Ltd. is a company founded by Dr. Bata, who developed the first technologies for the enzymatic inactivation of mycotoxins. It offers patented products for the biotechnological control of the most significant diseases affecting the animal industry.
drbata.com/es
